BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33376801)

  • 1. Terpenoids Commonly Found in
    Heblinski M; Santiago M; Fletcher C; Stuart J; Connor M; McGregor IS; Arnold JC
    Cannabis Cannabinoid Res; 2020; 5(4):305-317. PubMed ID: 33376801
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of Entourage: Terpenoids Commonly Found in
    Santiago M; Sachdev S; Arnold JC; McGregor IS; Connor M
    Cannabis Cannabinoid Res; 2019; 4(3):165-176. PubMed ID: 31559333
    [No Abstract]   [Full Text] [Related]  

  • 3. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
    De Petrocellis L; Vellani V; Schiano-Moriello A; Marini P; Magherini PC; Orlando P; Di Marzo V
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1007-15. PubMed ID: 18354058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
    Russo EB
    Br J Pharmacol; 2011 Aug; 163(7):1344-64. PubMed ID: 21749363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis.
    Fonseca BM; Correia-da-Silva G; Teixeira NA
    J Physiol Biochem; 2018 May; 74(2):261-272. PubMed ID: 29441458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting cannabinoid and vanilloid mechanisms for epilepsy treatment.
    Asth L; Iglesias LP; De Oliveira AC; Moraes MFD; Moreira FA
    Epilepsy Behav; 2021 Aug; 121(Pt B):106832. PubMed ID: 31839498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid Ligands Targeting TRP Channels.
    Muller C; Morales P; Reggio PH
    Front Mol Neurosci; 2018; 11():487. PubMed ID: 30697147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Critical Evaluation of Terpenoid Signaling at Cannabinoid CB1 Receptors in a Neuronal Model.
    Dvorakova M; Wilson S; Corey W; Billingsley J; Zimmowitch A; Tracey J; Straiker A; Mackie K
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid Receptors.
    Finlay DB; Sircombe KJ; Nimick M; Jones C; Glass M
    Front Pharmacol; 2020; 11():359. PubMed ID: 32269529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and comparison of recombinant human and rat TRPV1 receptors: effects of exo- and endocannabinoids.
    Lam PM; McDonald J; Lambert DG
    Br J Anaesth; 2005 May; 94(5):649-56. PubMed ID: 15722382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses.
    Walsh KB; McKinney AE; Holmes AE
    Front Pharmacol; 2021; 12():777804. PubMed ID: 34916950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miogadial and miogatrial with alpha,beta-unsaturated 1,4-dialdehyde moieties--novel and potent TRPA1 agonists.
    Iwasaki Y; Tanabe M; Kayama Y; Abe M; Kashio M; Koizumi K; Okumura Y; Morimitsu Y; Tominaga M; Ozawa Y; Watanabe T
    Life Sci; 2009 Jul; 85(1-2):60-9. PubMed ID: 19409911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity.
    Miyano K; Minami K; Yokoyama T; Ohbuchi K; Yamaguchi T; Murakami S; Shiraishi S; Yamamoto M; Matoba M; Uezono Y
    Anesth Analg; 2015 Apr; 120(4):790-8. PubMed ID: 25642661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terpenoids and Phytocannabinoids Co-Produced in
    Namdar D; Voet H; Ajjampura V; Nadarajan S; Mayzlish-Gati E; Mazuz M; Shalev N; Koltai H
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31438532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Targets of the Phytocannabinoids: A Complex Picture.
    Morales P; Hurst DP; Reggio PH
    Prog Chem Org Nat Prod; 2017; 103():103-131. PubMed ID: 28120232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terpenoids, Cannabimimetic Ligands, beyond the
    Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemical composition of ethanolic extracts from six genotypes of medical cannabis (Cannabis sativa L.) and their selective cytotoxic activity.
    Janatová A; Doskočil I; Božik M; Fraňková A; Tlustoš P; Klouček P
    Chem Biol Interact; 2022 Feb; 353():109800. PubMed ID: 34995571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.